Rocket Pharmaceuticals, Inc. (RCKT)
2.64
+0.04
(+1.54%)
USD |
NASDAQ |
Jun 11, 13:24
Rocket Pharmaceuticals 1 Year Total Returns (Daily) : -17.72% for June 10, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 10, 2026 | -17.72% |
| June 09, 2026 | -12.25% |
| June 08, 2026 | -11.91% |
| June 05, 2026 | -0.72% |
| June 04, 2026 | 0.00% |
| June 03, 2026 | -1.35% |
| June 02, 2026 | 4.33% |
| June 01, 2026 | 20.32% |
| May 29, 2026 | 17.18% |
| May 28, 2026 | 21.77% |
| May 27, 2026 | 28.33% |
| May 26, 2026 | -52.15% |
| May 22, 2026 | -54.88% |
| May 21, 2026 | -52.81% |
| May 20, 2026 | -56.64% |
| May 19, 2026 | -54.73% |
| May 18, 2026 | -52.77% |
| May 15, 2026 | -51.67% |
| May 14, 2026 | -43.85% |
| May 13, 2026 | -45.58% |
| May 12, 2026 | -48.00% |
| May 11, 2026 | -48.64% |
| May 08, 2026 | -48.44% |
| May 07, 2026 | -45.22% |
| May 06, 2026 | -38.83% |
| Date | Value |
|---|---|
| May 05, 2026 | -54.90% |
| May 04, 2026 | -54.93% |
| May 01, 2026 | -54.71% |
| April 30, 2026 | -54.39% |
| April 29, 2026 | -52.20% |
| April 28, 2026 | -52.10% |
| April 27, 2026 | -51.73% |
| April 24, 2026 | -52.62% |
| April 23, 2026 | -48.46% |
| April 22, 2026 | -45.48% |
| April 21, 2026 | -48.95% |
| April 20, 2026 | -39.02% |
| April 17, 2026 | -38.23% |
| April 16, 2026 | -36.59% |
| April 15, 2026 | -40.58% |
| April 14, 2026 | -38.41% |
| April 13, 2026 | -30.93% |
| April 10, 2026 | -29.35% |
| April 09, 2026 | -33.33% |
| April 08, 2026 | -24.84% |
| April 07, 2026 | -32.95% |
| April 06, 2026 | -32.42% |
| April 02, 2026 | -43.65% |
| April 01, 2026 | -37.69% |
| March 31, 2026 | -46.33% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Replimune Group, Inc. | -16.39% |
| ProKidney Corp. | 67.00% |
| Arrowhead Pharmaceuticals, Inc. | 316.8% |
| Oncolytics Biotech, Inc. | 87.38% |
| Sangamo Therapeutics, Inc. | -71.08% |